Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,577 | 613 | 99.9% |
| Education | $12.74 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,506 | 135 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $960.64 | 55 | $0 (2024) |
| Merck Sharp & Dohme LLC | $926.17 | 84 | $0 (2024) |
| Lilly USA, LLC | $640.95 | 46 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $523.77 | 36 | $0 (2024) |
| PFIZER INC. | $508.17 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $484.71 | 34 | $0 (2023) |
| GlaxoSmithKline, LLC. | $410.33 | 29 | $0 (2024) |
| ABBVIE INC. | $349.71 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $252.37 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,599 | 96 | AstraZeneca Pharmaceuticals LP ($383.93) |
| 2023 | $1,606 | 96 | Novo Nordisk Inc ($254.57) |
| 2022 | $1,155 | 78 | Novo Nordisk Inc ($148.86) |
| 2021 | $801.70 | 61 | Novo Nordisk Inc ($168.12) |
| 2020 | $560.31 | 48 | Novo Nordisk Inc ($112.06) |
| 2019 | $649.85 | 59 | Novo Nordisk Inc ($243.04) |
| 2018 | $1,093 | 91 | Merck Sharp & Dohme Corporation ($259.83) |
| 2017 | $1,125 | 86 | Merck Sharp & Dohme Corporation ($298.12) |
All Payment Transactions
615 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Biological | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: VACCINES | ||||||
| 09/23/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: WOMENS HEALTH | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 583 | 878 | $236,095 | $50,398 |
| 2022 | 14 | 689 | 1,011 | $240,568 | $48,554 |
| 2021 | 11 | 536 | 771 | $189,129 | $37,851 |
| 2020 | 12 | 588 | 703 | $113,341 | $41,261 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 271 | 562 | $160,188 | $29,398 | 18.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $19,198 | $7,604 | 39.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 59 | 59 | $8,260 | $4,244 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 43 | $13,400 | $2,449 | 18.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 74 | $4,020 | $2,432 | 60.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $20,140 | $2,314 | 11.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,305 | $887.49 | 68.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $8,960 | $787.28 | 8.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $624.00 | $282.27 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 539 | $153,192 | $27,660 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 73 | $19,540 | $4,168 | 21.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 57 | 60 | $8,400 | $4,008 | 47.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 81 | 85 | $3,825 | $2,740 | 71.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 16 | 18 | $8,136 | $1,718 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $16,720 | $1,568 | 9.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 23 | 23 | $3,220 | $1,567 | 48.7% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 32 | 32 | $3,840 | $1,375 | 35.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 23 | 27 | $4,725 | $1,076 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,340 | $1,005 | 23.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 22 | 22 | $12,320 | $949.23 | 7.7% |
| 90471 | Administration of vaccine | Office | 2022 | 23 | 33 | $1,815 | $361.23 | 19.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $495.00 | $359.37 | 72.6% |
| 91312 | Coronavirus vaccine 13 | Office | 2022 | 32 | 32 | $0.32 | $0.32 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 250 | 461 | $129,916 | $23,993 | 18.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 68 | $13,327 | $3,385 | 25.4% |
About Dr. Jasmine Bajaj, MD
Dr. Jasmine Bajaj, MD is a Family Medicine healthcare provider based in Burlington, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1285992875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasmine Bajaj, MD has received a total of $8,590 in payments from pharmaceutical and medical device companies, with $1,599 received in 2024. These payments were reported across 615 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,577).
As a Medicare-enrolled provider, Bajaj has provided services to 2,396 Medicare beneficiaries, totaling 3,363 services with total Medicare billing of $178,064. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Burlington, NJ
- Active Since 05/02/2012
- Last Updated 01/27/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285992875
Products in Payments
- Ozempic (Drug) $489.37
- JARDIANCE (Drug) $455.20
- JANUVIA (Drug) $385.98
- FARXIGA (Drug) $369.55
- Wegovy (Drug) $275.42
- AIRSUPRA (Drug) $257.13
- TRULICITY (Drug) $222.14
- Rybelsus (Drug) $191.73
- UBRELVY (Drug) $190.17
- SOLIQUA 100/33 (Biological) $182.26
- CHANTIX (Drug) $178.26
- XARELTO (Drug) $171.45
- Saxenda (Drug) $167.14
- Tresiba (Drug) $163.88
- Cologuard Collection Kit (Device) $149.06
- MOUNJARO (Drug) $143.28
- BREO (Drug) $143.17
- TRELEGY ELLIPTA (Drug) $136.33
- ENTRESTO (Drug) $134.85
- PNEUMOVAX 23 (Biological) $134.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Burlington
Krichna Sowles, Md, MD
Family Medicine — Payments: $17,218
Dr. Richard Gilbert, Md, MD
Family Medicine — Payments: $7,905
Michol Negron, D.o, D.O
Family Medicine — Payments: $7,588
Dr. Donald Fisher, Md, MD
Family Medicine — Payments: $7,370
Christopher Jarvis, M.d, M.D
Family Medicine — Payments: $5,691
Jeff Sloyer, M.d, M.D
Family Medicine — Payments: $5,178